Related Experiment Video
Updated: May 25, 2026
08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Insulin resistance in the nervous system
1University of Michigan, Department of Neurology, Ann Arbor, MI 48109, USA. bhumsoo@med.umich.edu
Trends in Endocrinology and Metabolism: TEM
|January 17, 2012
Summary
Neurons can develop insulin resistance (IR), similar to fat and muscle cells. This neuronal IR impairs insulin signaling, leading to nervous system injury and potentially contributing to neurological disorders like Alzheimer's disease.
Area of Science:
- Neuroscience
- Metabolic disorders
- Endocrinology
Background:
- Metabolic syndrome involves cardiovascular risk factors like obesity, diabetes, and dyslipidemia.
- Insulin resistance (IR) is central to metabolic syndrome, impairing insulin signaling in tissues like adipose and muscle.
- Neuronal IR, induced by hyperinsulinemia, may injure nervous systems and contribute to neurological diseases.
Purpose of the Study:
- To review evidence on neuronal insulin resistance.
- To explore the link between neuronal IR and neurological disorders.
- To highlight the pathogenic role of impaired insulin signaling in neurons.
Main Methods:
- Literature review of studies investigating insulin signaling in neurons.
- Analysis of evidence linking hyperinsulinemia-induced IR to neuronal dysfunction.
- Synthesis of findings on the role of IR in diabetic neuropathy and Alzheimer's disease.
Main Results:
- Neurons, like other metabolically active tissues, can develop insulin resistance.
- Neuronal IR hinders the response to insulin's neurotrophic effects.
- Impaired insulin signaling in neurons leads to injury, dysfunction, and disease.
Conclusions:
- Neuronal insulin resistance is a significant factor in nervous system pathology.
- Understanding neuronal IR is crucial for addressing neurological disorders.
- Targeting insulin signaling pathways may offer therapeutic strategies for neurodegenerative diseases.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...